Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENMIN LIMITED Director's Dealing 2025

Dec 17, 2025

64979_rns_2025-12-17_aae37e1b-cd4d-4bb0-b0dc-2981e4a5459e.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

ntroduced 30/09/01 Amended 01/01/11
Name of entity Genmin Limited
ABN 81 141 425 292

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Greg Lilleyman
Date of last notice 9 December 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Invia Custodian Pty Limited as custodian for
Injiview Pty Ltd (Injiview) and Injiview in its
capacity as trustee for the Lilleyman Family
Trust are the registered holders. Greg
Lilleyman is a director and shareholder of
Injiview.
Date of change 18 December 2025
No. of securities held prior to change 1,000,000 fully paid ordinary shares
900,000 performance rights expiring on 30
May 2029
Class (a) Fully paid ordinary shares
(b) Options exercisable at $0.015 and expiring
on 18 December 2027
Number acquired 308,482,152 fully paid ordinary shares
154,241,076 options exercisable at $0.015
and expiring on 18 December 2027
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
(a) $0.01 per fully paid ordinary share
(b) Nil (free attaching options)
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change 309,482,152 fully paid ordinary shares
900,000 performance rights expiring on 30
May 2029
154,241,076 options exercisable at $0.015
and expiring on 18 December 2027
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Issue of securities under tranche 2 of the
placement announced on 17 November
2025, as approved by shareholders at the
extraordinary general meeting held on 16
December 2025.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a
contract in relation to which the
interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash,
provide details and an estimated
valuation
N/A
Interest after change N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above
traded during a+closed period where prior written clearance was
required?
No
If so, was prior written clearance provided to allow the trade to
proceed during this period?
N/A
If prior written clearance was provided, on what date was this
provided?
N/A

This document is authorised for release to the market by:

Dennis Wilkins Company Secretary

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3